The 2010 World Stem Cell Summit, held in Detroit, included topics covering new developments in the field of regenerative medicine. This conference report highlights selected presentations on the cancer stem cell hypothesis, stem cell therapy for amyotrophic lateral sclerosis, GRNOPC-1 for spinal cord injury, the use of cord blood stem cells for spinal cord injury, mesenchymal stem cell research and applications in cardiac therapy, tissue engineering, and very small embryonic-like stem cells. Investigational drugs discussed include NSI-566RSC (Neuralstem) and GRNOPC-1 (Geron Corp)
Keywords : Amyotrophic Lateral Sclerosis,Animals,blood,Humans,injuries,metabolism,Neoplasms,Spinal Cord,Spinal Cord Injuries,Stem Cell Transplantation,Stem Cells,therapy,Tissue Engineering,trends,Ventricular Dysfunction,, World,Stem,Cell,Summitpart2, heathrow airport to waterloo station by tube
Date of Publication : 2010 Dec
Authors : Vertes A;
Organisation : London Business School, Regent’s Park, London, NW1 4SA, UK. avertes.sln2004@london.edu
Journal of Publication : IDrugs
Pubmed Link : https://www.ncbi.nlm.nih.gov/pubmed/21154133
The London Spine Unit : Harley Street UK. Specialists in Cutting Edge Technologies for Spinal Surgery
English
Arabic
Chinese (Simplified)
Russian
Spanish
Urdu